Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · IEX Real-Time Price · USD
0.701
-0.021 (-2.91%)
At close: Jul 2, 2024, 4:00 PM
0.737
+0.036 (5.06%)
After-hours: Jul 2, 2024, 7:56 PM EDT
Seres Therapeutics Market Cap
Seres Therapeutics has a market cap or net worth of $106.17 million as of July 2, 2024. Its market cap has decreased by -84.34% in one year.
Market Cap
106.17M
Enterprise Value
200.73M
1-Year Change
-84.34%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since June 26, 2015, Seres Therapeutics's market cap has decreased from $1.88B to $106.17M, a decrease of -94.36%. That is a compound annual growth rate of -27.30%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 109.30M | -39.61% |
Dec 29, 2023 | 181.00M | -74.06% |
Dec 30, 2022 | 697.70M | -8.81% |
Dec 31, 2021 | 765.10M | -65.78% |
Dec 31, 2020 | 2.24B | 825.71% |
Dec 31, 2019 | 241.50M | 30.75% |
Dec 31, 2018 | 184.70M | -55.06% |
Dec 29, 2017 | 411.00M | 2.88% |
Dec 30, 2016 | 399.50M | -70.85% |
Dec 31, 2015 | 1.37B | -27.26% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Akoya Biosciences | 115.56M |
Omega Therapeutics | 114.17M |
Corvus Pharmaceuticals | 113.84M |
Journey Medical | 112.87M |
DiaMedica Therapeutics | 111.99M |
Sagimet Biosciences | 109.15M |
Seer, Inc. | 109.09M |
DIH Holdings US | 108.25M |